It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
High mortality after discharge from hospital following acute illness has been observed among children with Severe Acute Malnutrition (SAM). However, mechanisms that may be amenable to intervention to reduce risk are unknown. We performed a nested case-control study among HIV-uninfected children aged 2–59 months treated for complicated SAM according to WHO recommendations at four Kenyan hospitals. Blood was drawn from 1778 children when clinically judged stable before discharge from hospital. Cases were children who died within 60 days. Controls were randomly selected children who survived for one year without readmission to hospital. Untargeted proteomics, total protein, cytokines and chemokines, and leptin were assayed in plasma and corresponding biological processes determined. Among 121 cases and 120 controls, increased levels of calprotectin, von Willebrand factor, angiotensinogen, IL8, IL15, IP10, TNFα, and decreased levels of leptin, heparin cofactor 2, and serum paraoxonase were associated with mortality after adjusting for possible confounders. Acute phase responses, cellular responses to lipopolysaccharide, neutrophil responses to bacteria, and endothelial responses were enriched among cases. Among apparently clinically stable children with SAM, a sepsis-like profile is associated with subsequent death. This may be due to ongoing bacterial infection, translocated bacterial products or deranged immune response during nutritional recovery.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 The Childhood Acute Illness & Nutrition (CHAIN) Network, Nairobi, Kenya; KEMRI/Wellcome Trust Research Programme, Kilifi, Kenya (GRID:grid.33058.3d) (ISNI:0000 0001 0155 5938)
2 The Childhood Acute Illness & Nutrition (CHAIN) Network, Nairobi, Kenya (GRID:grid.33058.3d); KEMRI/Wellcome Trust Research Programme, Kilifi, Kenya (GRID:grid.33058.3d) (ISNI:0000 0001 0155 5938)
3 KEMRI/Wellcome Trust Research Programme, Kilifi, Kenya (GRID:grid.33058.3d) (ISNI:0000 0001 0155 5938)
4 Faculty of Medicine and Health Sciences, Ghent University, Department of Gastroenterology, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798); Flemish Institute for Biotechnology, Inflammation Research Centre, Ghent, Belgium (GRID:grid.11486.3a) (ISNI:0000000104788040)
5 The Childhood Acute Illness & Nutrition (CHAIN) Network, Nairobi, Kenya (GRID:grid.11486.3a); The Hospital for Sick Children, Centre for Global Child Health, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646)
6 The Childhood Acute Illness & Nutrition (CHAIN) Network, Nairobi, Kenya (GRID:grid.42327.30); Medicine, Paediatrics and Epidemiology, University of Washington, Departments of Global Health, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
7 African Population and Health Research Centre, Nairobi, Kenya (GRID:grid.413355.5) (ISNI:0000 0001 2221 4219)
8 The Childhood Acute Illness & Nutrition (CHAIN) Network, Nairobi, Kenya (GRID:grid.413355.5); KEMRI/Wellcome Trust Research Programme, Kilifi, Kenya (GRID:grid.33058.3d) (ISNI:0000 0001 0155 5938); University of Oxford, Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)